Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11208-11219
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11208
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11208
Table 1 Characteristics of the included elderly patients with heart failure and reduced ejection according to the frailty status
Frail (n = 135) | Pre-frail (n = 93) | P value | |
Demographic factors | |||
Age (yr) | 70.7 ± 7.2 | 68.8 ± 5.8 | 0.039 |
Female, n (%) | 44 (32.6) | 25 (26.9) | 0.022 |
NYHA Class | |||
III, n (%) | 70 (51.9) | 57 (61.3) | 0.249 |
IV, n (%) | 44 (32.6) | 23 (24.7) | 0.010 |
Medical history | |||
Hypertension, n (%) | 78 (57.8) | 48 (51.6) | 0.358 |
DM, n (%) | 57 (42.2) | 29 (31.2) | 0.091 |
Dyslipidemia, n (%) | 34 (25.2) | 17 (18.3) | 0.219 |
AF, n (%) | 40 (29.6) | 18 (19.4) | 0.080 |
PAD, n (%) | 9 (6.7) | 8 (8.6) | 0.585 |
CABG, n (%) | 15 (11.1) | 11 (11.8) | 0.867 |
PCI, n (%) | 24 (17.8) | 18 (19.4) | 0.763 |
Clinical parameters | |||
SBP (mmHg) | 107.71 ± 21.03 | 114.01 ± 23.39 | 0.035 |
DBP (mmHg) | 66.90 ± 13.57 | 72.03 ± 12.06 | 0.004 |
HR (bpm) | 88.16 ± 20.41 | 89.39 ± 19.77 | 0.653 |
ALT (U/L)1 | 39 (23, 79) | 35 (20, 71) | 0.347 |
SCr (μmol/L) | 109.70 ± 65.63 | 102.67 ± 54.03 | 0.395 |
FPG (mmol/L) | 9.01 ± 6.32 | 8.49 ± 4.18 | 0.499 |
TG (mmol/L)1 | 1.4 (0.9, 1.8) | 1.5 (1.0, 2.1) | 0.082 |
LDL-C (mmol/L) | 2.59 ± 0.77 | 3.44 ± 1.51 | 0.455 |
HDL-C (mmol/L) | 1.05 ± 0.31 | 0.99 ± 0.31 | 0.901 |
PaO2 (mmHg) | 96.85 ± 33.03 | 101.12 ± 38.93 | 0.374 |
BNP (μmol/L)1 | 712 (329, 1422) | 542 (307, 925) | 0.189 |
Echocardiography | |||
LVEDD (mm) | 56.81 ± 9.01 | 54.46 ± 7.66 | 0.036 |
LVESD (mm) | 41.97 ± 11.03 | 41.89 ± 9.98 | 0.956 |
LVEF (%) | 33.79 ± 6.06 | 34.03 ± 5.64 | 0.753 |
LV thrombosis, n (%) | 27 (20) | 9 (9.7) | 0.036 |
Medications | |||
Diuretics, n (%) | 101 (74.8) | 73 (78.5) | 0.521 |
ARAs, n (%) | 90 (66.7) | 55 (59.1) | 0.246 |
ACEIs/ARBs, n (%) | 75 (55.6) | 53 (57.0) | 0.830 |
Beta-blockers, n (%) | 114 (84.4) | 76(81.7) | 0.588 |
Digitalis, n (%) | 51 (37.8) | 23 (24.7) | 0.039 |
Anticoagulants, n (%) | 65 (48.1) | 33 (35.5) | 0.058 |
Table 2 Physical performance of the included patients evaluated by short physical performance battery according to the frailty status (mean ± SD)
Frail (n = 135) | Pre-frail (n = 93) | P value | |
Handgrip strength (kg) | |||
Men | 23.8 ± 4.1 | 25.1 ± 4.2 | 0.056 |
Women | 17.9 ± 3.4 | 21.2 ± 4.5 | 0.003 |
Balance test | 3.08 ± 0.68 | 3.42 ± 0.61 | < 0.001 |
Four-meter gait test | 2.19 ± 0.82 | 2.70 ± 0.76 | < 0.001 |
Chair stand test | 1.96 ± 0.77 | 2.83 ± 0.70 | < 0.001 |
Overall SPPB score | 7.24 ± 1.72 | 8.95 ± 1.44 | < 0.001 |
Table 3 Incidence of in-hospital mortality and the major causes of mortality during hospitalization according to the frailty status of the patients
Frail (n = 135) | Pre-frail (n = 93) | P value | |
In-hospital death | 16 (11.9) | 4 (4.3) | 0.048 |
Cardiac shock | 3 (2.2) | 2 (2.4) | 0.971 |
Malignant arrhythmia | 3 (2.2) | 1 (1.1) | 0.517 |
MOF | 10 (7.4) | 1 (1.1) | 0.028 |
Table 4 Patient characteristics and the composite outcome of in-hospital adverse events: Results of univariate analysis
With AEs (n = 86) | Without AEs (n = 142) | P value | |
Female, n (%) | 30 (34.9) | 39 (27.5) | 0.279 |
NYHA Class III/IV, n (%) | 79 (91.9) | 115 (80.9) | 0.010 |
Frailty, n (%) | 62 (72.1) | 73 (51.4) | 0.002 |
Hypertension, n (%) | 54 (62.8) | 72 (50.7) | 0.075 |
DM, n (%) | 33 (38.4) | 53 (37.3) | 0.874 |
Dyslipidemia, n (%) | 18 (20.9) | 33 (23.2) | 0.685 |
AF, n (%) | 28 (32.6) | 30 (21.1) | 0.055 |
Age (yr) | 72.05 ± 7.46 | 68.65 ± 5.90 | < 0.001 |
Handgrip strength (kg) | 22.26 ± 5.34 | 23.04 ± 4.44 | 0.030 |
Overall SPPB score | 7.50 ± 2.04 | 8.18 ± 1.61 | 0.006 |
SBP (mmHg) | 110.87 ± 23.24 | 109.92 ± 21.62 | 0.759 |
DBP (mmHg) | 69.34±15.13 | 68.78 ± 11.92 | 0.772 |
PaO2 (mmHg) | 99.23 ± 47.56 | 98.20 ± 25.87 | 0.853 |
LVEF (%) | 33.74 ± 6.45 | 33.97 ± 5.53 | 0.786 |
Table 5 Potential predictive efficacy of frailty on the composite outcome of in-hospital adverse events: results of multivariate logistic regression analysis
SE | OR | 95%CI | P value | |
Female | 0.410 | 0.422 | 0.189-0.943 | 0.035 |
Age | 0.029 | 1.090 | 1.029-1.154 | 0.003 |
NYHA Class III/IV | 0.253 | 2.167 | 1.320-3.559 | 0.002 |
Frailty | 0.351 | 2.379 | 1.196-4.733 | 0.014 |
Overall SPPB Score | 0.100 | 0.945 | 0.776-1.150 | 0.570 |
Handgrip strength | 0.047 | 1.106 | 1.010-1.212 | 0.030 |
SBP | 0.007 | 1.003 | 0.989-1.017 | 0.656 |
LVEF | 0.027 | 0.990 | 0.939-1.042 | 0.694 |
- Citation: Kang YP, Chen LY, Zhu JJ, Liu WX, Ma CS. Association of frailty with in-hospital outcomes in elderly patients with heart failure. World J Clin Cases 2021; 9(36): 11208-11219
- URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11208.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11208